home · filing · 0001104659-22-082995
8-K
filed July 27, 2022, 7:59 PM ET
ticker HYPD
CIK 0001682639
leadership
confidence high
sentiment neutral
materiality 0.70
Eyenovia appoints COO Michael Rowe as CEO; Ianchulev becomes Executive Chairman
HYPERION DEFI, INC.
Michael Rowe, current COO, named CEO effective August 1, 2022; also appointed to Board of Directors.
Dr. Sean Ianchulev transitions from CEO to Executive Chairman; consulting agreement at $5,000 monthly retainer for one year.
Rowe's employment terms: $575,000 annual salary, up to 60% cash bonus, and option for 440,000 shares of common stock.
Upcoming milestones: MydCombi NDA resubmission, VISION-2 presbyopia trial completion, and MicroLine NDA preparation.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Michael Rowe
Director
HYPD ·
HYPERION DEFI, INC.
Effective 2022-08-01
Filed July 27, 2022, 7:59 PM ET
Mr. Rowe will also serve as a member of the Board, effective as of August 1, 2022
Role change
Michael Rowe
Chief Executive Officer
HYPD ·
HYPERION DEFI, INC.
Effective 2022-08-01
Filed July 27, 2022, 7:59 PM ET
On July 26, 2022, the Board appointed Michael Rowe as the Company’s Chief Executive Officer.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Michael Rowe was appointed as Director at HYPERION DEFI, INC..
Action appointed
Role Director
Exact text from the filing
Mr. Rowe will also serve as a member of the Board, effective as of August 1, 2022
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Michael Rowe was appointed as Chief Executive Officer at HYPERION DEFI, INC..
Action appointed
Role Chief Executive Officer
Exact text from the filing
On July 26, 2022, the Board appointed Michael Rowe as the Company’s Chief Executive Officer.
View on SEC.gov
Source: SEC EDGAR
accession 0001104659-22-082995
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.